PAR Stock View

Par Drugs and Chemicals Ltd

₹ 231.6

Market Cap ₹( Cr.)
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
Proj. Revenue ( Cr.)

Stock View

Last Updated On.

The average score for Par Drugs and Chemicals Ltd stands at 6 against 9, three months back.

Par Drugs and Chemicals Limited is an India-based company that is primarily engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets. The Company also produces a range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products having a capacity of approximately 9,700 metric tons per annum.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required